OMA Calls Ordinary Shareholders’ Meeting
Feb 08, 2017 13:03 pm UTC| Business
MONTERREY, Mexico, Feb. 08, 2017 -- Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA (NASDAQ:OMAB) (BMV:OMA), today published a call for an Ordinary Shareholders’ Meeting to be...
Feb 08, 2017 13:03 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2017 -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that the U.S. Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) has informed...
OMA Calls Ordinary Shareholders’ Meeting
Feb 08, 2017 13:03 pm UTC| Business
MONTERREY, Mexico, Feb. 08, 2017 -- Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA (NASDAQ:OMAB) (BMV:OMA), today published a call for an Ordinary Shareholders’ Meeting to be...
OMA Calls Ordinary Shareholders’ Meeting
Feb 08, 2017 13:03 pm UTC| Business
MONTERREY, Mexico, Feb. 08, 2017 -- Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA (NASDAQ:OMAB) (BMV:OMA), today published a call for an Ordinary Shareholders’ Meeting to be...
OMA Calls Ordinary Shareholders’ Meeting
Feb 08, 2017 13:03 pm UTC| Business
MONTERREY, Mexico, Feb. 08, 2017 -- Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA (NASDAQ:OMAB) (BMV:OMA), today published a call for an Ordinary Shareholders’ Meeting to be...
OPKO Spain to Start Trial of Once-A-Year Intra-Articular Injectable for Osteoarthritis
Feb 08, 2017 13:03 pm UTC| Business
MIAMI, Feb. 08, 2017 -- OPKO Health, Inc. (NASDAQ:OPK) today announced that its wholly owned subsidiary, OPKO Health Spain, has completed development of Enko 1, a patented intra-articular injectable hyaluronic acid and...
OPKO Spain to Start Trial of Once-A-Year Intra-Articular Injectable for Osteoarthritis
Feb 08, 2017 13:03 pm UTC| Business
MIAMI, Feb. 08, 2017 -- OPKO Health, Inc. (NASDAQ:OPK) today announced that its wholly owned subsidiary, OPKO Health Spain, has completed development of Enko 1, a patented intra-articular injectable hyaluronic acid and...